Skip to main content
NIH Record - National Institutes of Health

Increases in Inhaled Steroids Don’t Prevent Asthma Flare-Ups

Boy using an asthma inhaler while holding a football outside.

Temporarily increasing the dosage of inhaled steroids when asthma symptoms worsen does not prevent severe flare-ups.

Photo: CT757fan/iStock

Researchers have found that temporarily increasing the dosage of inhaled steroids when asthma symptoms begin to worsen does not effectively prevent severe flare-ups and may be associated with slowing a child’s growth. This challenges a common medical practice involving children with mild to moderate asthma.  

The study, funded by NHLBI, appeared Mar. 8 in the New England Journal of Medicine.

Asthma flare-ups in children are common and costly. To prevent them, many health professionals recommend increasing the doses of inhaled steroids from low to high at early signs of symptoms such as coughing, wheezing and shortness
of breath. 

Until now, researchers had not rigorously tested the safety and efficacy of this strategy in children with mild-to-moderate asthma.

“These findings suggest that a short-term increase to high-dose inhaled steroids should not be routinely included in asthma treatment plans for children with mild-moderate asthma who are regularly using low-dose inhaled corticosteroids,” said study leader Dr. Daniel Jackson of the University of Wisconsin School of Medicine and Public Health. “Low-dose inhaled steroids remain the cornerstone of daily treatment in affected children.”

The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Associate Editor: Carla Garnett
Carla.Garnett@nih.gov

Staff Writers:

Eric Bock
Eric.Bock@nih.gov

Dana Talesnik
Dana.Talesnik@nih.gov

Back to Top